3RD ESO LUNG CANCER OBSERVATORY: INNOVATION AND CARE IN THE NEXT 12 MONTHS
Anti-PD1 and anti-PDL1 strategies in NSCLC: Their potential role in NSCLC treatment
E. Felip
Anti-PD1 and anti-PDL1 strategies in NSCLC: Their potential role in NSCLC treatment
E. Felip
